Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas

被引:0
|
作者
Daniel ?kerberg [1 ]
Daniel Ansari [1 ]
Roland Andersson [1 ]
机构
[1] Department of Surgery, Clinical Sciences Lund, Lund University,and Sk?ne University Hospital
关键词
Pancreatic cancer; Survival; Prognostic factors;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
100214 ;
摘要
Pancreatic ductal adenocarcinoma carries a poor prognosis with annual deaths almost matching the reported incidence rates. Surgical resection offers the only potential cure. Yet, even among patients that undergo tumor resection, recurrence rates are high and long-term survival is scarce. Various tumorrelated factors have been identified as predictors of survival after potentially curative resection. These factors include tumor size, lymph node disease, tumor grade, vascular invasion, perineural invasion and surgical resection margin. This article will re-evaluate the importance of these factors based on recent publications on the topic, with potential implications for treatment and outcome in patients with pancreatic cancer.
引用
收藏
页码:6424 / 6433
页数:10
相关论文
共 50 条
  • [31] Prognostic factors in patients with locally advanced or borderline resectable pancreatic ductal adenocarcinoma: chemotherapy vs. chemoradiotherapy
    Seung-seob Kim
    Sunyoung Lee
    Hee Seung Lee
    Seungmin Bang
    Mi-Suk Park
    Abdominal Radiology, 2021, 46 : 655 - 666
  • [32] Diagnostic and Prognostic Value of Circulating KRAS Mutations in Resectable Pancreatic Ductal Adenocarcinoma
    Hipp, J.
    Hussung, S.
    Duyster, J.
    Fichtner-Feigl, S.
    Fritsch, R.
    Wittel, U. A.
    PANCREAS, 2018, 47 (10) : 1392 - 1392
  • [33] The role of flow cytometric DNA analysis in determining prognosis of resectable ductal adenocarcinoma of the pancreas
    Park, CS
    Wiebke, EA
    Sidner, RA
    Miller, GA
    Cummings, OW
    Howard, TJ
    Fineberg, NS
    Madura, JA
    AMERICAN SURGEON, 1996, 62 (07) : 609 - 616
  • [34] Search for new predictive/prognostic biomarkers in potentially resectable pancreatic ductal adenocarcinoma
    Gonzalez Borja, I.
    Viudez, A.
    Coni, S.
    Perez Sanz, J.
    Santamaria, E.
    Lopez-Lopez, C.
    Pazo, R.
    Jimenez Fonseca, P.
    Arevalo, S.
    Feliu, J.
    Fernandez Irigoyan, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [35] HISTOPATHOLOGIC PROGNOSTIC FACTORS FOR DUCTAL CARCINOMA OF THE HEAD OF THE PANCREAS
    KAYAHARA, M
    NAGAKAWA, T
    KONISHI, I
    UENO, K
    OHTA, T
    KANNO, M
    AKIYAMA, T
    UEDA, N
    NAKANO, T
    MORI, K
    MIYAZAKI, I
    ONCOLOGY REPORTS, 1994, 1 (01) : 145 - 148
  • [36] Prognostic Value of Transfer Learning Based Features in Resectable Pancreatic Ductal Adenocarcinoma
    Zhang, Yucheng
    Lobo-Mueller, Edrise M.
    Karanicolas, Paul
    Gallinger, Steven
    Haider, Masoom A.
    Khalvati, Farzad
    FRONTIERS IN ARTIFICIAL INTELLIGENCE, 2020, 3
  • [37] PROGNOSTIC FACTORS FOR THE SPEED OF PROGRESSION OF HD RESULTS OF A RE-EVALUATION OF THE RILUZOLE STUDY
    Gaus, W.
    Einsiedler, B.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 : A32 - A32
  • [38] MYXEDEMA COMA - PROGNOSTIC AND THERAPEUTIC RE-EVALUATION
    FENICHEL, P
    ZARTARIANA, M
    FRIMAUD, D
    BRUCKER, F
    MORAND, P
    HARTER, M
    PRESSE MEDICALE, 1988, 17 (26): : 1345 - 1348
  • [39] Re-evaluation of the correction factors for the GROVEX
    Ketelhut, Steffen
    Meier, Markus
    METROLOGIA, 2018, 55 (02) : 201 - 210
  • [40] FACTORS INFLUENCING SURVIVAL AFTER RESECTION FOR DUCTAL ADENOCARCINOMA OF THE PANCREAS
    MANNELL, A
    WEILAND, LH
    VANHEERDEN, JA
    ILSTRUP, DM
    ANNALS OF SURGERY, 1986, 203 (04) : 403 - 407